3 - 6 മാസത്തേക്കുള്ള മികച്ച മ്യൂച്വൽ ഫണ്ട്

Updated on August 3, 2026 , 112323 views

3 മുതൽ 6 മാസം വരെയുള്ള ചെറിയ കാലയളവിലേക്ക്, നിങ്ങൾക്ക് ഒന്നുകിൽ നിങ്ങളുടെ പണം പാർക്ക് ചെയ്യാംലിക്വിഡ് മ്യൂച്വൽ ഫണ്ടുകൾ അല്ലെങ്കിൽ അൾട്രാ ഷോർട്ട് ടേംകടം മ്യൂച്വൽ ഫണ്ട്. ദ്രാവകമ്യൂച്വൽ ഫണ്ടുകൾ സാധാരണയായി ഗവൺമെന്റ് സെക്യൂരിറ്റികളിലും 3 മാസം വരെയുള്ള നിക്ഷേപ സർട്ടിഫിക്കറ്റുകളിലും നിക്ഷേപിക്കുക.

എന്നിരുന്നാലും ഉയർന്ന റിട്ടേണുകൾക്കായി റിസ്ക് എടുക്കാൻ ഒരാൾ ഉത്സുകനാണെങ്കിൽ ചുവടെയുള്ള കുറച്ച് ഓപ്ഷനുകൾ നോക്കാം

3 മാസത്തെ മികച്ച 5 മ്യൂച്വൽ ഫണ്ടുകൾ

ഇവയുടെ ലിസ്റ്റ് ചുവടെയുണ്ട്മികച്ച മ്യൂച്വൽ ഫണ്ടുകൾ മൊത്തം ആസ്തി കഴിഞ്ഞു100 കോടി കൂടാതെ കഴിഞ്ഞ 3 മാസങ്ങളിൽ മികച്ച വരുമാനം നൽകി.

1. SBI Healthcare Opportunities Fund

(Erstwhile SBI Pharma Fund)

To provide the investors maximum growth opportunity through equity investments in stocks of growth oriented sectors of the economy.

Research Highlights for SBI Healthcare Opportunities Fund

Upper mid AUM (₹4,998 Cr).
Established history (21+ yrs).
Rating: 2★ (lower mid).
Risk profile: High.
5Y return: 17.02% (top quartile).
3Y return: 23.26% (upper mid).
1Y return: 19.30% (upper mid).
Alpha: 2.23 (lower mid).
Sharpe: 0.59 (top quartile).
Information ratio: -0.17 (lower mid).
Higher exposure to Health Care vs peer median.
Top bond sector: Cash Equivalent.
Equity-heavy allocation (~97%).
High-quality debt (AAA/AA ~100%).
Largest holding Sun Pharmaceuticals Industries Ltd (~11.2%).

Below is the key information for SBI Healthcare Opportunities Fund

SBI Healthcare Opportunities Fund Growth
Launch Date	31 Dec 04
NAV (05 Aug 26)	₹516.705 ↑ 0.43 (0.08 %)
Net Assets (Cr)	₹4,998 on 30 Jun 26
Category	Equity - Sectoral
AMC	SBI Funds Management Private Limited
Rating	☆☆
Risk	High
Expense Ratio	1.97
Sharpe Ratio	0.59
Information Ratio	-0.17
Alpha Ratio	2.23
Min Investment	5,000
Min SIP Investment	500
Exit Load	0-15 Days (0.5%),15 Days and above(NIL)

Growth of 10,000 investment over the years.

Date	Value
31 Jul 21	₹10,000
31 Jul 22	₹8,982
31 Jul 23	₹11,731
31 Jul 24	₹16,334
31 Jul 25	₹18,834
31 Jul 26	₹21,900

SBI Healthcare Opportunities Fund SIP Returns

Total investment amount is ₹300,000
expected amount after 5 Years is ₹470,047.
Net Profit of ₹170,047 Invest Now

Returns for SBI Healthcare Opportunities Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 5 Aug 26

Duration	Returns
1 Month	3.1%
3 Month	15.5%
6 Month	25.7%
1 Year	19.3%
3 Year	23.3%
5 Year	17%
10 Year
15 Year
Since launch	15.7%

Historical performance (Yearly) on absolute basis

Year	Returns
2025	-3.5%
2024	42.2%
2023	38.2%
2022	-6%
2021	20.1%
2020	65.8%
2019	-0.5%
2018	-9.9%
2017	2.1%
2016	-14%

Fund Manager information for SBI Healthcare Opportunities Fund

Name	Since	Tenure
Tanmaya Desai	1 Jun 11	15.18 Yr.

Data below for SBI Healthcare Opportunities Fund as on 30 Jun 26

Equity Sector Allocation

Sector	Value
Health Care	88.1%
Basic Materials	9.07%

Asset Allocation

Asset Class	Value
Cash	2.77%
Equity	97.17%
Debt	0.06%

Top Securities Holdings / Portfolio

Name	Holding	Value	Quantity
Sun Pharmaceuticals Industries Ltd (Healthcare) Equity, Since 31 Dec 17 \| SUNPHARMA	11%	₹559 Cr	3,000,000 ↑ 200,000
Acutaas Chemicals Ltd (Basic Materials) Equity, Since 30 Jun 24 \| 543349	6%	₹317 Cr	900,000
Divi's Laboratories Ltd (Healthcare) Equity, Since 31 Mar 12 \| DIVISLAB	6%	₹296 Cr	450,000
Apollo Hospitals Enterprise Ltd (Healthcare) Equity, Since 31 Jan 26 \| APOLLOHOSP	5%	₹260 Cr	300,000
Max Healthcare Institute Ltd Ordinary Shares (Healthcare) Equity, Since 31 Mar 21 \| MAXHEALTH	5%	₹254 Cr	2,250,000
Aurobindo Pharma Ltd (Healthcare) Equity, Since 31 Mar 26 \| AUROPHARMA	4%	₹208 Cr	1,320,000 ↑ 70,000
Aster DM Healthcare Ltd Ordinary Shares (Healthcare) Equity, Since 31 Mar 24 \| ASTERDM	4%	₹188 Cr	2,400,000
Laurus Labs Ltd (Healthcare) Equity, Since 31 Aug 23 \| 540222	4%	₹182 Cr	1,200,000
Cipla Ltd (Healthcare) Equity, Since 31 May 26 \| 500087	4%	₹176 Cr	1,200,000 ↑ 600,000
Torrent Pharmaceuticals Ltd (Healthcare) Equity, Since 30 Jun 21 \| TORNTPHARM	3%	₹166 Cr	360,000

2. Motilal Oswal Focused 25 Fund

(Erstwhile Motilal Oswal MOSt Focused 25 Fund)

The investment objective of the Scheme is to achieve long term capital appreciation by investing in upto 25 companies with long term sustainable competitive advantage and growth potential. However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved.

Research Highlights for Motilal Oswal Focused 25 Fund

Bottom quartile AUM (₹1,635 Cr).
Established history (13+ yrs).
Top rated.
Risk profile: Moderately High.
5Y return: 9.78% (lower mid).
3Y return: 12.38% (lower mid).
1Y return: 21.15% (top quartile).
Alpha: 12.39 (top quartile).
Sharpe: 0.35 (lower mid).
Information ratio: -0.21 (bottom quartile).
Top sector: Financial Services.
Top bond sector: Cash Equivalent.
Equity-heavy allocation (~94%).
Largest holding Rubicon Research Ltd (~4.4%).

Below is the key information for Motilal Oswal Focused 25 Fund

Motilal Oswal Focused 25 Fund Growth
Launch Date	7 May 13
NAV (05 Aug 26)	₹51.7739 ↑ 0.47 (0.92 %)
Net Assets (Cr)	₹1,635 on 30 Jun 26
Category	Equity - Focused
AMC	Motilal Oswal Asset Management Co. Ltd
Rating	☆☆☆
Risk	Moderately High
Expense Ratio	1.97
Sharpe Ratio	0.35
Information Ratio	-0.21
Alpha Ratio	12.39
Min Investment	5,000
Min SIP Investment	500
Exit Load	0-1 Years (1%),1 Years and above(NIL)

Growth of 10,000 investment over the years.

Date	Value
31 Jul 21	₹10,000
31 Jul 22	₹10,120
31 Jul 23	₹11,523
31 Jul 24	₹15,422
31 Jul 25	₹13,725
31 Jul 26	₹15,997

Motilal Oswal Focused 25 Fund SIP Returns

Total investment amount is ₹300,000
expected amount after 5 Years is ₹385,859.
Net Profit of ₹85,859 Invest Now

Returns for Motilal Oswal Focused 25 Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 5 Aug 26

Duration	Returns
1 Month	5.6%
3 Month	14.6%
6 Month	20.6%
1 Year	21.2%
3 Year	12.4%
5 Year	9.8%
10 Year
15 Year
Since launch	13.2%

Historical performance (Yearly) on absolute basis

Year	Returns
2025	-1.7%
2024	13.6%
2023	18.8%
2022	2%
2021	14.6%
2020	17.3%
2019	17.1%
2018	-4.2%
2017	32.2%
2016	2.8%

Fund Manager information for Motilal Oswal Focused 25 Fund

Name	Since	Tenure
Varun Sharma	14 Aug 25	0.96 Yr.
Swapnil Mayekar	18 Nov 25	0.7 Yr.
Ankit Agarwal	5 Aug 25	0.99 Yr.
Rakesh Shetty	22 Nov 22	3.69 Yr.
Atul Mehra	1 Oct 24	1.83 Yr.

Data below for Motilal Oswal Focused 25 Fund as on 30 Jun 26

Equity Sector Allocation

Sector	Value
Financial Services	24.62%
Industrials	23.13%
Consumer Cyclical	18.96%
Health Care	8.46%
Technology	7.86%
Communication Services	3.06%
Utility	2.93%
Basic Materials	2.66%

Asset Allocation

Asset Class	Value
Cash	6.44%
Equity	93.56%

Top Securities Holdings / Portfolio

Name	Holding	Value	Quantity
Rubicon Research Ltd (Healthcare) Equity, Since 30 Apr 26 \| RUBICON	4%	₹73 Cr	518,073 ↑ 13,036
AU Small Finance Bank Ltd (Financial Services) Equity, Since 31 Oct 25 \| 540611	4%	₹69 Cr	669,589 ↑ 23,881
Eternal Ltd (Consumer Cyclical) Equity, Since 31 Jan 26 \| ETERNAL	4%	₹69 Cr	2,592,637 ↑ 62,681
CG Power & Industrial Solutions Ltd (Industrials) Equity, Since 28 Feb 26 \| 500093	4%	₹67 Cr	707,583
Aditya Infotech Ltd (Industrials) Equity, Since 28 Feb 26 \| CPPLUS	4%	₹66 Cr	181,175 ↓ -80,000
ICICI Prudential Asset Management Co Ltd (Financial Services) Equity, Since 31 Jan 26 \| ICICIAMC	4%	₹66 Cr	197,893 ↑ 4,703
Apollo Hospitals Enterprise Ltd (Healthcare) Equity, Since 28 Feb 26 \| APOLLOHOSP	4%	₹66 Cr	75,565
PNB Housing Finance Ltd (Financial Services) Equity, Since 31 May 26 \| PNBHOUSING	4%	₹57 Cr	553,533 ↑ 70,874
Titan Co Ltd (Consumer Cyclical) Equity, Since 31 Oct 25 \| TITAN	4%	₹57 Cr	130,247 ↑ 3,709
Gabriel India Ltd (Consumer Cyclical) Equity, Since 31 Aug 25 \| GABRIEL	3%	₹56 Cr	455,227 ↓ -81,000

3. UTI Healthcare Fund

(Erstwhile UTI Pharma & Healthcare Fund)

The Investment objective of the Scheme is capital appreciation through investments in equities and equity related instruments of the Pharma & Healthcare sectors.

Research Highlights for UTI Healthcare Fund

Bottom quartile AUM (₹1,308 Cr).
Established history (27+ yrs).
Rating: 1★ (bottom quartile).
Risk profile: High.
5Y return: 14.84% (upper mid).
3Y return: 23.28% (top quartile).
1Y return: 16.16% (lower mid).
Alpha: 2.15 (bottom quartile).
Sharpe: 0.58 (upper mid).
Information ratio: 0.20 (top quartile).
Higher exposure to Health Care vs peer median.
Top bond sector: Cash Equivalent.
Equity-heavy allocation (~95%).
Largest holding Sun Pharmaceuticals Industries Ltd (~8.5%).

Below is the key information for UTI Healthcare Fund

UTI Healthcare Fund Growth
Launch Date	28 Jun 99
NAV (05 Aug 26)	₹337.669 ↑ 1.01 (0.30 %)
Net Assets (Cr)	₹1,308 on 30 Jun 26
Category	Equity - Sectoral
AMC	UTI Asset Management Company Ltd
Rating	☆
Risk	High
Expense Ratio	2.26
Sharpe Ratio	0.58
Information Ratio	0.2
Alpha Ratio	2.15
Min Investment	5,000
Min SIP Investment	500
Exit Load	0-1 Years (1%),1 Years and above(NIL)

Growth of 10,000 investment over the years.

Date	Value
31 Jul 21	₹10,000
31 Jul 22	₹8,749
31 Jul 23	₹10,615
31 Jul 24	₹15,542
31 Jul 25	₹17,610
31 Jul 26	₹19,855

UTI Healthcare Fund SIP Returns

Total investment amount is ₹300,000
expected amount after 5 Years is ₹436,710.
Net Profit of ₹136,710 Invest Now

Returns for UTI Healthcare Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 5 Aug 26

Duration	Returns
1 Month	2.5%
3 Month	14.1%
6 Month	22.1%
1 Year	16.2%
3 Year	23.3%
5 Year	14.8%
10 Year
15 Year
Since launch	15%

Historical performance (Yearly) on absolute basis

Year	Returns
2025	-3.1%
2024	42.9%
2023	38.2%
2022	-12.3%
2021	19.1%
2020	67.4%
2019	1.2%
2018	-7.5%
2017	6.2%
2016	-9.7%

Fund Manager information for UTI Healthcare Fund

Name	Since	Tenure
Kamal Gada	2 May 22	4.25 Yr.

Data below for UTI Healthcare Fund as on 30 Jun 26

Equity Sector Allocation

Sector	Value
Health Care	95.05%

Asset Allocation

Asset Class	Value
Cash	4.95%
Equity	95.05%

Top Securities Holdings / Portfolio

Name	Holding	Value	Quantity
Sun Pharmaceuticals Industries Ltd (Healthcare) Equity, Since 31 Oct 06 \| SUNPHARMA	9%	₹112 Cr	600,000
Ajanta Pharma Ltd (Healthcare) Equity, Since 31 Jul 17 \| 532331	5%	₹66 Cr	194,021 ↓ -1,274
Divi's Laboratories Ltd (Healthcare) Equity, Since 30 Sep 17 \| DIVISLAB	5%	₹62 Cr	94,242 ↑ 5,428
Gland Pharma Ltd (Healthcare) Equity, Since 30 Nov 20 \| GLAND	4%	₹54 Cr	215,251
Caplin Point Laboratories Ltd (Healthcare) Equity, Since 31 Dec 23 \| CAPLIPOINT	4%	₹53 Cr	200,000 ↑ 15,000
Lupin Ltd (Healthcare) Equity, Since 28 Feb 25 \| 500257	4%	₹49 Cr	203,834
Apollo Hospitals Enterprise Ltd (Healthcare) Equity, Since 30 Apr 21 \| APOLLOHOSP	4%	₹46 Cr	53,000
Alkem Laboratories Ltd (Healthcare) Equity, Since 31 May 21 \| ALKEM	3%	₹41 Cr	73,830 ↑ 5,830
Dr Reddy's Laboratories Ltd (Healthcare) Equity, Since 28 Feb 18 \| DRREDDY	3%	₹39 Cr	290,000
Max Healthcare Institute Ltd Ordinary Shares (Healthcare) Equity, Since 31 Mar 24 \| MAXHEALTH	3%	₹39 Cr	344,969

4. UTI Equity Fund

This Scheme primarily aims at securing for the unitholders capital appreciation by investing the funds of the scheme in equity shares and convertible and non-convertible bonds/ debentures of companies with good growth prospects and money market instruments.

Research Highlights for UTI Equity Fund

Highest AUM (₹22,882 Cr).
Oldest track record among peers (34 yrs).
Rating: 3★ (upper mid).
Risk profile: Moderately High.
5Y return: 6.18% (bottom quartile).
3Y return: 9.35% (bottom quartile).
1Y return: 3.02% (bottom quartile).
Alpha: -6.34 (bottom quartile).
Sharpe: -0.69 (bottom quartile).
Information ratio: -0.98 (bottom quartile).
Top sector: Financial Services.
Top bond sector: Cash Equivalent.
Equity-heavy allocation (~97%).
High-quality debt (AAA/AA ~100%).
Largest holding Bajaj Finance Ltd (~6.3%).

Below is the key information for UTI Equity Fund

UTI Equity Fund Growth
Launch Date	18 May 92
NAV (05 Aug 26)	₹332.072 ↑ 0.09 (0.03 %)
Net Assets (Cr)	₹22,882 on 30 Jun 26
Category	Equity - Multi Cap
AMC	UTI Asset Management Company Ltd
Rating	☆☆☆
Risk	Moderately High
Expense Ratio	1.66
Sharpe Ratio	-0.7
Information Ratio	-0.98
Alpha Ratio	-6.34
Min Investment	5,000
Min SIP Investment	500
Exit Load	0-1 Years (1%),1 Years and above(NIL)

Growth of 10,000 investment over the years.

Date	Value
31 Jul 21	₹10,000
31 Jul 22	₹9,828
31 Jul 23	₹10,501
31 Jul 24	₹13,048
31 Jul 25	₹13,441
31 Jul 26	₹13,609

UTI Equity Fund SIP Returns

Total investment amount is ₹300,000
expected amount after 5 Years is ₹357,992.
Net Profit of ₹57,992 Invest Now

Returns for UTI Equity Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 5 Aug 26

Duration	Returns
1 Month	6.1%
3 Month	13.2%
6 Month	6.6%
1 Year	3%
3 Year	9.3%
5 Year	6.2%
10 Year
15 Year
Since launch	12.7%

Historical performance (Yearly) on absolute basis

Year	Returns
2025	1.1%
2024	14.3%
2023	19.8%
2022	-13.4%
2021	34%
2020	31.5%
2019	11.7%
2018	3.5%
2017	30.1%
2016	1.1%

Fund Manager information for UTI Equity Fund

Name	Since	Tenure
Ajay Tyagi	11 Jan 16	10.47 Yr.
Kamal Gada	8 Apr 25	1.23 Yr.
Akash Shah	12 Jan 26	0.46 Yr.

Data below for UTI Equity Fund as on 30 Jun 26

Equity Sector Allocation

Sector	Value
Financial Services	23.79%
Consumer Cyclical	22.82%
Health Care	12.37%
Technology	11.16%
Communication Services	7.92%
Industrials	7.41%
Consumer Defensive	5.84%
Basic Materials	5.68%

Asset Allocation

Asset Class	Value
Cash	2.79%
Equity	96.98%
Debt	0.22%

Top Securities Holdings / Portfolio

Name	Holding	Value	Quantity
Bajaj Finance Ltd (Financial Services) Equity, Since 30 Nov 17 \| 500034	6%	₹1,432 Cr	14,251,000 ↓ -755,500
ICICI Bank Ltd (Financial Services) Equity, Since 31 Oct 21 \| ICICIBANK	6%	₹1,428 Cr	10,384,000 ↓ -552,000
Eternal Ltd (Consumer Cyclical) Equity, Since 31 Jul 21 \| ETERNAL	6%	₹1,357 Cr	51,295,000 ↑ 643,300
HDFC Bank Ltd (Financial Services) Equity, Since 31 May 07 \| HDFCBANK	5%	₹1,219 Cr	15,273,000 ↓ -208,600
Titan Co Ltd (Consumer Cyclical) Equity, Since 31 Jul 11 \| TITAN	4%	₹926 Cr	2,102,200 ↓ -21,000
Avenue Supermarts Ltd (Consumer Defensive) Equity, Since 31 Jul 19 \| 540376	4%	₹831 Cr	1,896,750 ↓ -12,250
Bharti Airtel Ltd (Communication Services) Equity, Since 31 Jan 20 \| BHARTIARTL	3%	₹788 Cr	4,256,000 ↑ 73,700
Kotak Mahindra Bank Ltd (Financial Services) Equity, Since 30 Apr 15 \| KOTAKBANK	3%	₹772 Cr	19,690,000 ↓ -1,096,000
Coforge Ltd (Technology) Equity, Since 31 Jul 21 \| COFORGE	3%	₹755 Cr	5,148,500 ↓ -181,500
Dixon Technologies (India) Ltd (Technology) Equity, Since 31 Aug 23 \| DIXON	3%	₹705 Cr	591,400 ↓ -17,590

5. Aditya Birla Sun Life Digital India Fund

(Erstwhile Aditya Birla Sun Life New Millennium Fund)

A multi-sector open-ended growth scheme with the objective of long term growth of capital, through a portfolio with a target allocation of 100% equity, focusing on investing in technology and technology dependent companies, hardware, peripherals and components, software, telecom, media, internet and e-commerce and other technology enabled companies. The secondary objective is income generation and distribution of dividend.

Research Highlights for Aditya Birla Sun Life Digital India Fund

Lower mid AUM (₹3,589 Cr).
Established history (26+ yrs).
Rating: 2★ (bottom quartile).
Risk profile: High.
5Y return: 5.74% (bottom quartile).
3Y return: 6.71% (bottom quartile).
1Y return: -2.65% (bottom quartile).
Alpha: 3.86 (upper mid).
Sharpe: -1.27 (bottom quartile).
Information ratio: -0.12 (upper mid).
Higher exposure to Technology vs peer median.
Top bond sector: Cash Equivalent.
Equity-heavy allocation (~95%).
Largest holding Infosys Ltd (~13.8%).

Below is the key information for Aditya Birla Sun Life Digital India Fund

Aditya Birla Sun Life Digital India Fund Growth
Launch Date	15 Jan 00
NAV (04 Aug 26)	₹161.22 ↑ 0.13 (0.08 %)
Net Assets (Cr)	₹3,589 on 30 Jun 26
Category	Equity - Sectoral
AMC	Birla Sun Life Asset Management Co Ltd
Rating	☆☆
Risk	High
Expense Ratio	1.88
Sharpe Ratio	-1.27
Information Ratio	-0.12
Alpha Ratio	3.86
Min Investment	1,000
Min SIP Investment	100
Exit Load	0-365 Days (1%),365 Days and above(NIL)

Growth of 10,000 investment over the years.

Date	Value
31 Jul 21	₹10,000
31 Jul 22	₹9,628
31 Jul 23	₹10,858
31 Jul 24	₹15,010
31 Jul 25	₹13,808
31 Jul 26	₹13,047

Aditya Birla Sun Life Digital India Fund SIP Returns

Total investment amount is ₹300,000
expected amount after 5 Years is ₹349,120.
Net Profit of ₹49,120 Invest Now

Returns for Aditya Birla Sun Life Digital India Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 5 Aug 26

Duration	Returns
1 Month	12.7%
3 Month	12.8%
6 Month	-5%
1 Year	-2.7%
3 Year	6.7%
5 Year	5.7%
10 Year
15 Year
Since launch	11%

Historical performance (Yearly) on absolute basis

Year	Returns
2025	-5.2%
2024	18.1%
2023	35.8%
2022	-21.6%
2021	70.5%
2020	59%
2019	9.6%
2018	15.6%
2017	22.4%
2016	-3.5%

Fund Manager information for Aditya Birla Sun Life Digital India Fund

Name	Since	Tenure
Kunal Sangoi	16 Jan 14	12.55 Yr.

Data below for Aditya Birla Sun Life Digital India Fund as on 30 Jun 26

Equity Sector Allocation

Sector	Value
Technology	61.01%
Consumer Cyclical	12%
Communication Services	11.05%
Industrials	5.97%
Financial Services	3.26%
Consumer Defensive	1.09%

Asset Allocation

Asset Class	Value
Cash	1.53%
Equity	94.89%
Other	3.59%

Top Securities Holdings / Portfolio

Name	Holding	Value	Quantity
Infosys Ltd (Technology) Equity, Since 30 Apr 05 \| INFY	14%	₹497 Cr	4,967,365
Bharti Airtel Ltd (Communication Services) Equity, Since 31 Aug 19 \| BHARTIARTL	10%	₹350 Cr	1,888,549 ↓ -51,420
Tech Mahindra Ltd (Technology) Equity, Since 31 May 13 \| 532755	8%	₹279 Cr	1,986,223 ↓ -125,772
Eternal Ltd (Consumer Cyclical) Equity, Since 31 Jul 21 \| ETERNAL	7%	₹254 Cr	9,604,831
Tata Consultancy Services Ltd (Technology) Equity, Since 30 Apr 05 \| TCS	6%	₹231 Cr	1,136,378 ↓ -72,437
Coforge Ltd (Technology) Equity, Since 30 Jun 20 \| COFORGE	5%	₹190 Cr	1,296,695
LTM Ltd (Technology) Equity, Since 31 Mar 21 \| LTM	4%	₹154 Cr	434,328
Persistent Systems Ltd (Technology) Equity, Since 31 Jul 13 \| PERSISTENT	4%	₹135 Cr	311,131
Bmo Global Innovators Fund Series - I - \| -	4%	₹129 Cr	588,130 ↑ 205
Swiggy Ltd (Consumer Cyclical) Equity, Since 30 Nov 24 \| SWIGGY	4%	₹127 Cr	5,292,110 ↑ 172,308

6 മാസത്തെ മികച്ച 5 മ്യൂച്വൽ ഫണ്ടുകൾ

മൊത്തം ആസ്തിയുള്ള മികച്ച മ്യൂച്വൽ ഫണ്ടുകളുടെ ലിസ്റ്റ് ചുവടെയുണ്ട്100 കോടി കൂടാതെ കഴിഞ്ഞ 6 മാസങ്ങളിൽ മികച്ച വരുമാനം നൽകി.

1. SBI Healthcare Opportunities Fund

(Erstwhile SBI Pharma Fund)

To provide the investors maximum growth opportunity through equity investments in stocks of growth oriented sectors of the economy.

Research Highlights for SBI Healthcare Opportunities Fund

Highest AUM (₹4,998 Cr).
Established history (21+ yrs).
Rating: 2★ (lower mid).
Risk profile: High.
5Y return: 17.02% (lower mid).
3Y return: 23.26% (lower mid).
1Y return: 19.30% (lower mid).
Alpha: 2.23 (lower mid).
Sharpe: 0.59 (upper mid).
Information ratio: -0.17 (lower mid).
Higher exposure to Health Care vs peer median.
Top bond sector: Cash Equivalent.
Equity-heavy allocation (~97%).
High-quality debt (AAA/AA ~100%).
Largest holding Sun Pharmaceuticals Industries Ltd (~11.2%).

Below is the key information for SBI Healthcare Opportunities Fund

SBI Healthcare Opportunities Fund Growth
Launch Date	31 Dec 04
NAV (05 Aug 26)	₹516.705 ↑ 0.43 (0.08 %)
Net Assets (Cr)	₹4,998 on 30 Jun 26
Category	Equity - Sectoral
AMC	SBI Funds Management Private Limited
Rating	☆☆
Risk	High
Expense Ratio	1.97
Sharpe Ratio	0.59
Information Ratio	-0.17
Alpha Ratio	2.23
Min Investment	5,000
Min SIP Investment	500
Exit Load	0-15 Days (0.5%),15 Days and above(NIL)

Growth of 10,000 investment over the years.

Date	Value
31 Jul 21	₹10,000
31 Jul 22	₹8,982
31 Jul 23	₹11,731
31 Jul 24	₹16,334
31 Jul 25	₹18,834
31 Jul 26	₹21,900

SBI Healthcare Opportunities Fund SIP Returns

Total investment amount is ₹300,000
expected amount after 5 Years is ₹470,047.
Net Profit of ₹170,047 Invest Now

Returns for SBI Healthcare Opportunities Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 5 Aug 26

Duration	Returns
1 Month	3.1%
3 Month	15.5%
6 Month	25.7%
1 Year	19.3%
3 Year	23.3%
5 Year	17%
10 Year
15 Year
Since launch	15.7%

Historical performance (Yearly) on absolute basis

Year	Returns
2025	-3.5%
2024	42.2%
2023	38.2%
2022	-6%
2021	20.1%
2020	65.8%
2019	-0.5%
2018	-9.9%
2017	2.1%
2016	-14%

Fund Manager information for SBI Healthcare Opportunities Fund

Name	Since	Tenure
Tanmaya Desai	1 Jun 11	15.18 Yr.

Data below for SBI Healthcare Opportunities Fund as on 30 Jun 26

Equity Sector Allocation

Sector	Value
Health Care	88.1%
Basic Materials	9.07%

Asset Allocation

Asset Class	Value
Cash	2.77%
Equity	97.17%
Debt	0.06%

Top Securities Holdings / Portfolio

Name	Holding	Value	Quantity
Sun Pharmaceuticals Industries Ltd (Healthcare) Equity, Since 31 Dec 17 \| SUNPHARMA	11%	₹559 Cr	3,000,000 ↑ 200,000
Acutaas Chemicals Ltd (Basic Materials) Equity, Since 30 Jun 24 \| 543349	6%	₹317 Cr	900,000
Divi's Laboratories Ltd (Healthcare) Equity, Since 31 Mar 12 \| DIVISLAB	6%	₹296 Cr	450,000
Apollo Hospitals Enterprise Ltd (Healthcare) Equity, Since 31 Jan 26 \| APOLLOHOSP	5%	₹260 Cr	300,000
Max Healthcare Institute Ltd Ordinary Shares (Healthcare) Equity, Since 31 Mar 21 \| MAXHEALTH	5%	₹254 Cr	2,250,000
Aurobindo Pharma Ltd (Healthcare) Equity, Since 31 Mar 26 \| AUROPHARMA	4%	₹208 Cr	1,320,000 ↑ 70,000
Aster DM Healthcare Ltd Ordinary Shares (Healthcare) Equity, Since 31 Mar 24 \| ASTERDM	4%	₹188 Cr	2,400,000
Laurus Labs Ltd (Healthcare) Equity, Since 31 Aug 23 \| 540222	4%	₹182 Cr	1,200,000
Cipla Ltd (Healthcare) Equity, Since 31 May 26 \| 500087	4%	₹176 Cr	1,200,000 ↑ 600,000
Torrent Pharmaceuticals Ltd (Healthcare) Equity, Since 30 Jun 21 \| TORNTPHARM	3%	₹166 Cr	360,000

2. UTI Healthcare Fund

(Erstwhile UTI Pharma & Healthcare Fund)

The Investment objective of the Scheme is capital appreciation through investments in equities and equity related instruments of the Pharma & Healthcare sectors.

Research Highlights for UTI Healthcare Fund

Lower mid AUM (₹1,308 Cr).
Oldest track record among peers (27 yrs).
Rating: 1★ (bottom quartile).
Risk profile: High.
5Y return: 14.84% (bottom quartile).
3Y return: 23.28% (upper mid).
1Y return: 16.16% (bottom quartile).
Alpha: 2.15 (bottom quartile).
Sharpe: 0.58 (lower mid).
Information ratio: 0.20 (top quartile).
Higher exposure to Health Care vs peer median.
Top bond sector: Cash Equivalent.
Equity-heavy allocation (~95%).
Largest holding Sun Pharmaceuticals Industries Ltd (~8.5%).

Below is the key information for UTI Healthcare Fund

UTI Healthcare Fund Growth
Launch Date	28 Jun 99
NAV (05 Aug 26)	₹337.669 ↑ 1.01 (0.30 %)
Net Assets (Cr)	₹1,308 on 30 Jun 26
Category	Equity - Sectoral
AMC	UTI Asset Management Company Ltd
Rating	☆
Risk	High
Expense Ratio	2.26
Sharpe Ratio	0.58
Information Ratio	0.2
Alpha Ratio	2.15
Min Investment	5,000
Min SIP Investment	500
Exit Load	0-1 Years (1%),1 Years and above(NIL)

Growth of 10,000 investment over the years.

Date	Value
31 Jul 21	₹10,000
31 Jul 22	₹8,749
31 Jul 23	₹10,615
31 Jul 24	₹15,542
31 Jul 25	₹17,610
31 Jul 26	₹19,855

UTI Healthcare Fund SIP Returns

Total investment amount is ₹300,000
expected amount after 5 Years is ₹436,710.
Net Profit of ₹136,710 Invest Now

Returns for UTI Healthcare Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 5 Aug 26

Duration	Returns
1 Month	2.5%
3 Month	14.1%
6 Month	22.1%
1 Year	16.2%
3 Year	23.3%
5 Year	14.8%
10 Year
15 Year
Since launch	15%

Historical performance (Yearly) on absolute basis

Year	Returns
2025	-3.1%
2024	42.9%
2023	38.2%
2022	-12.3%
2021	19.1%
2020	67.4%
2019	1.2%
2018	-7.5%
2017	6.2%
2016	-9.7%

Fund Manager information for UTI Healthcare Fund

Name	Since	Tenure
Kamal Gada	2 May 22	4.25 Yr.

Data below for UTI Healthcare Fund as on 30 Jun 26

Equity Sector Allocation

Sector	Value
Health Care	95.05%

Asset Allocation

Asset Class	Value
Cash	4.95%
Equity	95.05%

Top Securities Holdings / Portfolio

Name	Holding	Value	Quantity
Sun Pharmaceuticals Industries Ltd (Healthcare) Equity, Since 31 Oct 06 \| SUNPHARMA	9%	₹112 Cr	600,000
Ajanta Pharma Ltd (Healthcare) Equity, Since 31 Jul 17 \| 532331	5%	₹66 Cr	194,021 ↓ -1,274
Divi's Laboratories Ltd (Healthcare) Equity, Since 30 Sep 17 \| DIVISLAB	5%	₹62 Cr	94,242 ↑ 5,428
Gland Pharma Ltd (Healthcare) Equity, Since 30 Nov 20 \| GLAND	4%	₹54 Cr	215,251
Caplin Point Laboratories Ltd (Healthcare) Equity, Since 31 Dec 23 \| CAPLIPOINT	4%	₹53 Cr	200,000 ↑ 15,000
Lupin Ltd (Healthcare) Equity, Since 28 Feb 25 \| 500257	4%	₹49 Cr	203,834
Apollo Hospitals Enterprise Ltd (Healthcare) Equity, Since 30 Apr 21 \| APOLLOHOSP	4%	₹46 Cr	53,000
Alkem Laboratories Ltd (Healthcare) Equity, Since 31 May 21 \| ALKEM	3%	₹41 Cr	73,830 ↑ 5,830
Dr Reddy's Laboratories Ltd (Healthcare) Equity, Since 28 Feb 18 \| DRREDDY	3%	₹39 Cr	290,000
Max Healthcare Institute Ltd Ordinary Shares (Healthcare) Equity, Since 31 Mar 24 \| MAXHEALTH	3%	₹39 Cr	344,969

3. Motilal Oswal Focused 25 Fund

(Erstwhile Motilal Oswal MOSt Focused 25 Fund)

Research Highlights for Motilal Oswal Focused 25 Fund

Upper mid AUM (₹1,635 Cr).
Established history (13+ yrs).
Rating: 3★ (upper mid).
Risk profile: Moderately High.
5Y return: 9.78% (bottom quartile).
3Y return: 12.38% (bottom quartile).
1Y return: 21.15% (upper mid).
Alpha: 12.39 (top quartile).
Sharpe: 0.35 (bottom quartile).
Information ratio: -0.21 (bottom quartile).
Higher exposure to Financial Services vs peer median.
Top bond sector: Cash Equivalent.
Equity-heavy allocation (~94%).
Largest holding Rubicon Research Ltd (~4.4%).

Below is the key information for Motilal Oswal Focused 25 Fund

Motilal Oswal Focused 25 Fund Growth
Launch Date	7 May 13
NAV (05 Aug 26)	₹51.7739 ↑ 0.47 (0.92 %)
Net Assets (Cr)	₹1,635 on 30 Jun 26
Category	Equity - Focused
AMC	Motilal Oswal Asset Management Co. Ltd
Rating	☆☆☆
Risk	Moderately High
Expense Ratio	1.97
Sharpe Ratio	0.35
Information Ratio	-0.21
Alpha Ratio	12.39
Min Investment	5,000
Min SIP Investment	500
Exit Load	0-1 Years (1%),1 Years and above(NIL)

Growth of 10,000 investment over the years.

Date	Value
31 Jul 21	₹10,000
31 Jul 22	₹10,120
31 Jul 23	₹11,523
31 Jul 24	₹15,422
31 Jul 25	₹13,725
31 Jul 26	₹15,997

Motilal Oswal Focused 25 Fund SIP Returns

Total investment amount is ₹300,000
expected amount after 5 Years is ₹385,859.
Net Profit of ₹85,859 Invest Now

Returns for Motilal Oswal Focused 25 Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 5 Aug 26

Duration	Returns
1 Month	5.6%
3 Month	14.6%
6 Month	20.6%
1 Year	21.2%
3 Year	12.4%
5 Year	9.8%
10 Year
15 Year
Since launch	13.2%

Historical performance (Yearly) on absolute basis

Year	Returns
2025	-1.7%
2024	13.6%
2023	18.8%
2022	2%
2021	14.6%
2020	17.3%
2019	17.1%
2018	-4.2%
2017	32.2%
2016	2.8%

Fund Manager information for Motilal Oswal Focused 25 Fund

Name	Since	Tenure
Varun Sharma	14 Aug 25	0.96 Yr.
Swapnil Mayekar	18 Nov 25	0.7 Yr.
Ankit Agarwal	5 Aug 25	0.99 Yr.
Rakesh Shetty	22 Nov 22	3.69 Yr.
Atul Mehra	1 Oct 24	1.83 Yr.

Data below for Motilal Oswal Focused 25 Fund as on 30 Jun 26

Equity Sector Allocation

Sector	Value
Financial Services	24.62%
Industrials	23.13%
Consumer Cyclical	18.96%
Health Care	8.46%
Technology	7.86%
Communication Services	3.06%
Utility	2.93%
Basic Materials	2.66%

Asset Allocation

Asset Class	Value
Cash	6.44%
Equity	93.56%

Top Securities Holdings / Portfolio

Name	Holding	Value	Quantity
Rubicon Research Ltd (Healthcare) Equity, Since 30 Apr 26 \| RUBICON	4%	₹73 Cr	518,073 ↑ 13,036
AU Small Finance Bank Ltd (Financial Services) Equity, Since 31 Oct 25 \| 540611	4%	₹69 Cr	669,589 ↑ 23,881
Eternal Ltd (Consumer Cyclical) Equity, Since 31 Jan 26 \| ETERNAL	4%	₹69 Cr	2,592,637 ↑ 62,681
CG Power & Industrial Solutions Ltd (Industrials) Equity, Since 28 Feb 26 \| 500093	4%	₹67 Cr	707,583
Aditya Infotech Ltd (Industrials) Equity, Since 28 Feb 26 \| CPPLUS	4%	₹66 Cr	181,175 ↓ -80,000
ICICI Prudential Asset Management Co Ltd (Financial Services) Equity, Since 31 Jan 26 \| ICICIAMC	4%	₹66 Cr	197,893 ↑ 4,703
Apollo Hospitals Enterprise Ltd (Healthcare) Equity, Since 28 Feb 26 \| APOLLOHOSP	4%	₹66 Cr	75,565
PNB Housing Finance Ltd (Financial Services) Equity, Since 31 May 26 \| PNBHOUSING	4%	₹57 Cr	553,533 ↑ 70,874
Titan Co Ltd (Consumer Cyclical) Equity, Since 31 Oct 25 \| TITAN	4%	₹57 Cr	130,247 ↑ 3,709
Gabriel India Ltd (Consumer Cyclical) Equity, Since 31 Aug 25 \| GABRIEL	3%	₹56 Cr	455,227 ↓ -81,000

4. DSP US Flexible Equity Fund

The primary investment objective of the Scheme is to seek capital appreciation by investing predominantly in units of BGF – USFEF. The Scheme may, at the discretion of the Investment Manager also invest in the units of other similar overseas mutual fund schemes, which may constitute a significant part of its corpus. The Scheme may also invest a certain portion of its corpus in money market securities and/or money market/liquid schemes of DSP BlackRock Mutual Fund, in order to meet liquidity requirements from time to time. However, there is no assurance that the investment objective of the Scheme will be realized. It shall be noted ‘similar overseas mutual fund schemes’ shall have investment objective, investment strategy and risk profile/consideration similar to those of BGF – USFEF.

Research Highlights for DSP US Flexible Equity Fund

Bottom quartile AUM (₹1,291 Cr).
Established history (14+ yrs).
Top rated.
Risk profile: High.
5Y return: 18.43% (top quartile).
3Y return: 26.43% (top quartile).
1Y return: 42.06% (top quartile).
Alpha: -4.10 (bottom quartile).
Sharpe: 1.93 (top quartile).
Information ratio: 0.15 (upper mid).
Higher exposure to Technology vs peer median.
Higher exposure to Cash Equivalent (bond sector) vs peer median.
Equity-heavy allocation (~94%).
Largest holding BGF US Flexible Equity I2 (~95.7%).
Top-3 holdings concentration ~100.4%.

Below is the key information for DSP US Flexible Equity Fund

DSP US Flexible Equity Fund Growth
Launch Date	3 Aug 12
NAV (04 Aug 26)	₹94.0243 ↑ 1.81 (1.96 %)
Net Assets (Cr)	₹1,291 on 30 Jun 26
Category	Equity - Global
AMC	DSP BlackRock Invmt Managers Pvt. Ltd.
Rating	☆☆☆☆☆
Risk	High
Expense Ratio	1.55
Sharpe Ratio	1.93
Information Ratio	0.15
Alpha Ratio	-4.1
Min Investment	1,000
Min SIP Investment	500
Exit Load	0-12 Months (1%),12 Months and above(NIL)

Growth of 10,000 investment over the years.

Date	Value
31 Jul 21	₹10,000
31 Jul 22	₹10,023
31 Jul 23	₹11,458
31 Jul 24	₹13,332
31 Jul 25	₹16,454
31 Jul 26	₹22,370

DSP US Flexible Equity Fund SIP Returns

Total investment amount is ₹300,000
expected amount after 5 Years is ₹481,656.
Net Profit of ₹181,656 Invest Now

Returns for DSP US Flexible Equity Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 5 Aug 26

Duration	Returns
1 Month	-0.5%
3 Month	4.1%
6 Month	20.1%
1 Year	42.1%
3 Year	26.4%
5 Year	18.4%
10 Year
15 Year
Since launch	17.4%

Historical performance (Yearly) on absolute basis

Year	Returns
2025	33.8%
2024	17.8%
2023	22%
2022	-5.9%
2021	24.2%
2020	22.6%
2019	27.5%
2018	-1.1%
2017	15.5%
2016	9.8%

Fund Manager information for DSP US Flexible Equity Fund

Name	Since	Tenure
Kaivalya Nadkarni	1 May 25	1.25 Yr.

Data below for DSP US Flexible Equity Fund as on 30 Jun 26

Equity Sector Allocation

Sector	Value
Technology	32.18%
Communication Services	13.8%
Industrials	13.38%
Financial Services	12.1%
Consumer Cyclical	9.45%
Health Care	7.39%
Energy	2.14%
Basic Materials	2.13%
Utility	1.5%

Asset Allocation

Asset Class	Value
Cash	5.91%
Equity	94.07%
Debt	0.02%

Top Securities Holdings / Portfolio

Name	Holding	Value	Quantity
BGF US Flexible Equity I2 Investment Fund \| -	96%	₹1,236 Cr	1,784,131
Treps / Reverse Repo Investments CBLO/Reverse Repo \| -	4%	₹58 Cr
Net Receivables/Payables Net Current Assets \| -	0%	-₹3 Cr

5. IDBI Small Cap Fund

The Investment objective of the Scheme is to provide investors with the opportunities for long-term capital appreciation by investing predominantly in Equity and Equity related instruments of Small Cap companies. However there can be no assurance that the investment objective under the Scheme will be realized.

Research Highlights for IDBI Small Cap Fund

Bottom quartile AUM (₹743 Cr).
Established history (9+ yrs).
Not Rated.
Risk profile: Moderately High.
5Y return: 17.38% (upper mid).
3Y return: 17.54% (bottom quartile).
1Y return: 13.89% (bottom quartile).
Alpha: 9.18 (upper mid).
Sharpe: 0.27 (bottom quartile).
Information ratio: -0.23 (bottom quartile).
Top sector: Industrials.
Top bond sector: Cash Equivalent.
Equity-heavy allocation (~96%).
Largest holding Garware Hi-Tech Films Ltd (~4.9%).

Below is the key information for IDBI Small Cap Fund

IDBI Small Cap Fund Growth
Launch Date	21 Jun 17
NAV (05 Aug 26)	₹34.1206 ↑ 0.20 (0.60 %)
Net Assets (Cr)	₹743 on 30 Jun 26
Category	Equity - Small Cap
AMC	IDBI Asset Management Limited
Rating	Not Rated
Risk	Moderately High
Expense Ratio	2.3
Sharpe Ratio	0.27
Information Ratio	-0.23
Alpha Ratio	9.18
Min Investment	5,000
Min SIP Investment	500
Exit Load	0-12 Months (1%),12 Months and above(NIL)

Growth of 10,000 investment over the years.

Date	Value
31 Jul 21	₹10,000
31 Jul 22	₹11,314
31 Jul 23	₹13,804
31 Jul 24	₹21,537
31 Jul 25	₹20,034
31 Jul 26	₹21,938

IDBI Small Cap Fund SIP Returns

Total investment amount is ₹300,000
expected amount after 5 Years is ₹470,047.
Net Profit of ₹170,047 Invest Now

Returns for IDBI Small Cap Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 5 Aug 26

Duration	Returns
1 Month	1.4%
3 Month	9.4%
6 Month	19.6%
1 Year	13.9%
3 Year	17.5%
5 Year	17.4%
10 Year
15 Year
Since launch	14.4%

Historical performance (Yearly) on absolute basis

Year	Returns
2025	-13.4%
2024	40%
2023	33.4%
2022	2.4%
2021	64.7%
2020	19%
2019	-4.4%
2018	-15%
2017
2016

Fund Manager information for IDBI Small Cap Fund

Name	Since	Tenure
Dikshit Mittal	24 Jul 25	1.02 Yr.

Data below for IDBI Small Cap Fund as on 30 Jun 26

Equity Sector Allocation

Sector	Value
Industrials	23.79%
Consumer Cyclical	18.71%
Basic Materials	14.76%
Financial Services	12.22%
Consumer Defensive	9.96%
Technology	6.67%
Health Care	6.4%
Real Estate	1.43%
Utility	1.02%
Communication Services	0.89%

Asset Allocation

Asset Class	Value
Cash	4.17%
Equity	95.83%

Top Securities Holdings / Portfolio

Name	Holding	Value	Quantity
Garware Hi-Tech Films Ltd (Basic Materials) Equity, Since 30 Sep 25 \| 500655	5%	₹36 Cr	54,623 ↓ -3,838
Avalon Technologies Ltd (Technology) Equity, Since 31 Aug 23 \| AVALON	4%	₹29 Cr	162,956 ↓ -4,889
Manorama Industries Ltd (Consumer Defensive) Equity, Since 31 Dec 24 \| 541974	3%	₹24 Cr	142,461
Navin Fluorine International Ltd (Basic Materials) Equity, Since 30 Sep 19 \| NAVINFLUOR	3%	₹23 Cr	29,286
Allied Blenders and Distillers Ltd (Consumer Defensive) Equity, Since 31 Jul 24 \| ABDL	3%	₹22 Cr	326,615
Kirloskar Oil Engines Ltd (Industrials) Equity, Since 28 Feb 21 \| KIRLOSENG	3%	₹19 Cr	78,792
Schneider Electric Infrastructure Ltd (Industrials) Equity, Since 31 Aug 25 \| SCHNEIDER	2%	₹18 Cr	133,576
Arvind Fashions Ltd (Consumer Cyclical) Equity, Since 29 Feb 24 \| ARVINDFASN	2%	₹18 Cr	374,775 ↑ 13,091
KSH International Ltd (Industrials) Equity, Since 31 Dec 25 \| KSHINTL	2%	₹17 Cr	201,146 ↓ -32,069
Tata Motors Passenger Vehicles Ltd (Consumer Cyclical) Equity, Since 31 May 26 \| TMPV	2%	₹14 Cr	408,034 ↑ 200,288

മ്യൂച്വൽ ഫണ്ടുകളിൽ ഓൺലൈനിൽ എങ്ങനെ നിക്ഷേപിക്കാം?

Fincash.com-ൽ ആജീവനാന്ത സൗജന്യ നിക്ഷേപ അക്കൗണ്ട് തുറക്കുക.

നിങ്ങളുടെ രജിസ്ട്രേഷനും KYC പ്രക്രിയയും പൂർത്തിയാക്കുക

രേഖകൾ അപ്‌ലോഡ് ചെയ്യുക (പാൻ, ആധാർ മുതലായവ).കൂടാതെ, നിങ്ങൾ നിക്ഷേപിക്കാൻ തയ്യാറാണ്!

തുടങ്ങി

Disclaimer:
ഇവിടെ നൽകിയിരിക്കുന്ന വിവരങ്ങൾ കൃത്യമാണെന്ന് ഉറപ്പാക്കാൻ എല്ലാ ശ്രമങ്ങളും നടത്തിയിട്ടുണ്ട്. എന്നിരുന്നാലും, ഡാറ്റയുടെ കൃത്യത സംബന്ധിച്ച് യാതൊരു ഉറപ്പും നൽകുന്നില്ല. എന്തെങ്കിലും നിക്ഷേപം നടത്തുന്നതിന് മുമ്പ് സ്കീം വിവര രേഖ ഉപയോഗിച്ച് പരിശോധിക്കുക.